La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Serotonin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Serotonergic Neurons < Serotonin < Serotonin 5-HT1 Receptor Agonists  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000547 (2014) Safa Bouabid ; Claire Delaville ; Philippe De Deurwaerdère ; Nouria Lakhdar-Ghazal ; Abdelhamid BenazzouzManganese-induced atypical parkinsonism is associated with altered Basal Ganglia activity and changes in tissue levels of monoamines in the rat.
000595 (2014) Gurdal Sahin ; Lachlan H. Thompson ; Sonia Lavisse ; Merve Ozgur ; Latifa Rbah-Vidal ; Frédéric Dollé ; Philippe Hantraye ; Deniz KirikDifferential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
000678 (2013) P. De Deurwaerdère ; M. Lagière ; M. Bosc ; S. NavaillesMultiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.
000679 (2013) M. Lagière ; S. Navailles ; L. Mignon ; A. Roumegous ; M-F Chesselet ; P. De DeurwaerdèreThe enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates.
000733 (2013) S. Navailles ; M. Lagière ; A. Contini ; P. De DeurwaerdèreMultisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.
000809 (2012) P. De Deurwaerdère ; S. NavaillesWhat can we expect from the serotonergic side of L-DOPA?
000825 (2012) David Grabli ; Carine Karachi ; Marie-Laure Welter ; Brian Lau ; Etienne C. Hirsch ; Marie Vidailhet ; Chantal FrançoisNormal and pathological gait: what we learn from Parkinson's disease.
000891 (2012) Sylvia Navailles ; Philippe De DeurwaerdèreContribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.
000895 (2012) C. Delaville ; S. Navailles ; A. BenazzouzEffects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
000921 (2011) Sylvia Navailles ; Manolo Carta ; Martin Guthrie ; Philippe De DeurwaerdèreL-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease.
000A05 (2011) Sylvia Navailles ; Bernard Bioulac ; Christian Gross ; Philippe De DeurwaerdèreChronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.
000A06 (2011) Sylvia Navailles ; Philippe De DeurwaerdèrePresynaptic control of serotonin on striatal dopamine function.
000B08 (2010) Sylvia Navailles ; Abdelhamid Benazzouz ; Bernard Bioulac ; Christian Gross ; Philippe De DeurwaerdèreHigh-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.
000D46 (2007) Stéphanie Mounayar ; Sabrina Boulet ; Dominique Tandé ; Caroline Jan ; Mathias Pessiglione ; Etienne C. Hirsch ; Jean Féger ; Marc Savasta ; Chantal François ; Léon TremblayA new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
001073 (2003) Benjamin Di Cara ; Denise Samuel ; Pascal Salin ; Lydia Kerkerian-Le Goff ; Annie DaszutaSerotonergic regulation of the GABAergic transmission in the rat basal ganglia.
001392 (????) S. Bourgoin ; S. Rostaing-Rigattieri ; J P Nguyen ; E. Berberich ; P. Duvaldestin ; C M Fattaccini ; M. Hamon ; F. CesselinOpposite changes in dopamine metabolites and met-enkephalin levels in the ventricular CSF of patients subjected to thalamic electrical stimulation.
001438 (1999) O. RascolL-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
001739 (1993) P. Gaspar ; A. Febvret ; J. ColomboSerotonergic sprouting in primate MTP-induced hemiparkinsonism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Serotonin" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Serotonin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Serotonin
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024